CRISPR Therapy Approved to Treat Blood Disorder That Causes Anemia
Healthline ,
Share on PinterestJulieanne Birch/ This month the FDA has approved a treatment for an inherited blood disorder.
Editas Medicine: A Mispriced Contender In The Gene Editing Arena
Seeking Alpha,
Summary Editas Medicine specializes in gene editing, targeting a range of serious illnesses, with a unique platform that covers…
Bristol Myers Squibb to Present First Results at ASCO and EHA from Phase 3 COMMANDS Study of Reblozyl® (luspatercept-aamt) in First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS)
Morning Star,
Results from Phase 3 COMMANDS study, selected for ASCO’s official press program, show nearly twice as many patients treated…
